Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

HB 475689th Legislature (2025)

Relating to certain advertisements for prescription drugs.

Introduced

Underlined text would be added to current law. Struck-through text would be removed.

  89R16099 SCR-D
 
  By: Bell of Montgomery H.B. No. 4756
 
 
  A BILL TO BE ENTITLED
  AN ACT
  relating to certain advertisements for prescription drugs.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Subtitle A, Title 16, Business & Commerce Code,
  is amended by adding Chapter 722 to read as follows:
  CHAPTER 722.  CERTAIN ADVERTISEMENTS FOR PRESCRIPTION DRUGS
         Sec. 722.001.  DEFINITION. In this chapter, "paid
  advertisement" means a communication that promotes a good or
  service and is disseminated in exchange for consideration.
         Sec. 722.002.  PROHIBITED ADVERTISEMENT OF CERTAIN
  PRESCRIPTION DRUGS.  (a)  A person may not disseminate a paid
  advertisement for a prescription drug.
         (b)  Subsection (a) does not apply to a paid advertisement
  disseminated:
               (1)  only to medical, dental, or nursing professionals
  in a professional scientific periodical; or
               (2)  only for public health education by a person who is
  not directly or indirectly commercially interested in the sale of
  the drug.
         Sec. 722.003.  DECEPTIVE TRADE PRACTICE. A violation of
  Section 722.002 is a deceptive trade practice in addition to the
  practices described by Subchapter E, Chapter 17, and is actionable
  under that subchapter.
         SECTION 2.  This Act takes effect September 1, 2025.

Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.